Summary

Photodynamic therapy (PDT) combines light-sensitive compounds with light exposure to selectively destroy diseased cells. It has established itself as a promising therapeutic option, particularly in treating skin cancers, age-related macular degeneration, and precancerous lesions. The therapy's non-invasive profile and minimal side effects make it increasingly favored by both healthcare professionals and patients. Additionally, technological upgrades in diode lasers and the introduction of next-generation photosensitizers are shaping the future of this treatment approach.

________________________________________

Factors Fueling Market Expansion

A key growth driver for the photodynamic therapy market is the rising global burden of cancer, particularly skin and head-neck cancers. As patients and physicians increasingly seek out non-surgical alternatives, PDT emerges as a suitable and effective treatment modality. Growing geriatric populations, who are more susceptible to such conditions, further expand the patient pool. Regulatory approvals for novel photosensitizers and integration of PDT into outpatient care protocols also support wider adoption. Technological innovation in compact and portable PDT devices is increasing their accessibility, especially in remote healthcare settings.

________________________________________

Challenges Hindering Market Penetration

Despite its growing use, the photodynamic therapy market faces several constraints. The limited awareness among patients and healthcare practitioners about PDT's benefits slows adoption in many regions. High initial equipment costs and treatment expenses may restrict uptake in developing economies. Furthermore, PDT’s applicability is largely limited to surface-level or easily accessible lesions, reducing its use for deep internal malignancies. Reimbursement limitations and the need for trained professionals to operate laser devices also act as growth deterrents, particularly in lower-income markets.

________________________________________

Untapped Growth Opportunities

The photodynamic therapy industry presents multiple avenues for future expansion. The integration of PDT with nanotechnology and immunotherapy is opening new research pathways, enhancing therapeutic precision and efficiency. Expanding applications into antimicrobial therapy, ophthalmology, and cardiovascular disease are also under exploration. Emerging economies, particularly in Asia-Pacific and Latin America, present lucrative prospects due to improving healthcare infrastructure and rising cancer incidence. Collaborations between research institutions and medical device companies can accelerate new product development and market reach.

________________________________________

Geographic Growth Landscape

North America remains the dominant region, driven by early technology adoption, advanced healthcare systems, and high awareness levels. The European market follows closely, supported by robust cancer screening programs and public health funding. Asia Pacific is expected to experience the fastest growth rate owing to increasing investments in healthcare infrastructure, government initiatives for cancer awareness, and rising disposable incomes in countries like China and India. Meanwhile, Latin America, South Asia & Pacific, and the Middle East & Africa are emerging markets with promising potential, albeit currently limited by access and affordability challenges.

________________________________________

Key Market Participants

Prominent players operating in the global photodynamic therapy market include:

• BASF SE

• Shiseido Company, Limited

• Avon Products, Inc.

• International Flavors & Fragrances Inc.

• L'Oréal Group

• Givaudan

• Firmenich SA

• MANE

• Clarins Fragrance Group

• COTY INC.

• LVMH

• VIORYL S.A.

• Zanos Ltd.

• Artiste

• INDESSO AROMA

• Aroma Chemical Services International GmbH

These companies are actively involved in research, product innovation, and strategic partnerships to enhance their market position. Investments are primarily focused on developing more effective photosensitizers, compact diode laser devices, and expanding product applications across a broader range of indications.

________________________________________

Market Segmentation

By Product Type

• Photosensitizer Drugs

o Aminolevulinic Acid

o Chlorines

o Porphyrin Derivatives

o Others

• Photodynamic Therapy Devices

o PDT Diode Lasers

o Others

By Application

• Cancer

• Skin Conditions

• Others

By Region

• North America

• Europe

• Latin America

• Asia Pacific

• The Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Photodynamic Therapy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Photodynamic Therapy Market Outlook, 2019-2032
3.1. Global Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Photosensitizer Drugs
3.1.1.1.1. Hematoporphyrin derivative (HpD)
3.1.1.1.2. Aminolevulinic acid (ALA)
3.1.1.1.3. Benzoporphyrin derivative (BPD)
3.1.1.1.4. Texaphyrins
3.1.1.1.5. Chlorins
3.1.1.1.6. Dyes
3.1.1.2. Devices
3.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
3.1.1.2.2. Diode Laser
3.2. Global Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Basal Cell Carcinoma
3.2.1.2. Actinic Keratosis
3.2.1.3. Others
3.2.1.3.1. Psoriasis
3.2.1.3.2. Acne
3.3. Global Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Private Dermatology Clinics
3.3.1.3. Laser Therapy Centers
3.3.1.4. Cancer Treatment Centers
3.3.1.5. Spas and Rejuvenation Centers
3.4. Global Photodynamic Therapy Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Photodynamic Therapy Market Outlook, 2019-2032
4.1. North America Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Photosensitizer Drugs
4.1.1.1.1. Hematoporphyrin derivative (HpD)
4.1.1.1.2. Aminolevulinic acid (ALA)
4.1.1.1.3. Benzoporphyrin derivative (BPD)
4.1.1.1.4. Texaphyrins
4.1.1.1.5. Chlorins
4.1.1.1.6. Dyes
4.1.1.2. Devices
4.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
4.1.1.2.2. Diode Laser
4.2. North America Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Basal Cell Carcinoma
4.2.1.2. Actinic Keratosis
4.2.1.3. Others
4.2.1.3.1. Psoriasis
4.2.1.3.2. Acne
4.3. North America Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Private Dermatology Clinics
4.3.1.3. Laser Therapy Centers
4.3.1.4. Cancer Treatment Centers
4.3.1.5. Spas and Rejuvenation Centers
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
4.4.1.2. U.S. Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
4.4.1.3. U.S. Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
4.4.1.4. Canada Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
4.4.1.5. Canada Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
4.4.1.6. Canada Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Photodynamic Therapy Market Outlook, 2019-2032
5.1. Europe Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Photosensitizer Drugs
5.1.1.1.1. Hematoporphyrin derivative (HpD)
5.1.1.1.2. Aminolevulinic acid (ALA)
5.1.1.1.3. Benzoporphyrin derivative (BPD)
5.1.1.1.4. Texaphyrins
5.1.1.1.5. Chlorins
5.1.1.1.6. Dyes
5.1.1.2. Devices
5.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
5.1.1.2.2. Diode Laser
5.2. Europe Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Basal Cell Carcinoma
5.2.1.2. Actinic Keratosis
5.2.1.3. Others
5.2.1.3.1. Psoriasis
5.2.1.3.2. Acne
5.3. Europe Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Private Dermatology Clinics
5.3.1.3. Laser Therapy Centers
5.3.1.4. Cancer Treatment Centers
5.3.1.5. Spas and Rejuvenation Centers
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
5.4.1.2. Germany Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
5.4.1.3. Germany Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
5.4.1.4. U.K. Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
5.4.1.5. U.K. Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
5.4.1.6. U.K. Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
5.4.1.7. France Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
5.4.1.8. France Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
5.4.1.9. France Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
5.4.1.10. Italy Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
5.4.1.11. Italy Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
5.4.1.12. Italy Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
5.4.1.13. Turkey Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
5.4.1.14. Turkey Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
5.4.1.15. Turkey Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
5.4.1.16. Russia Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
5.4.1.17. Russia Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
5.4.1.18. Russia Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
5.4.1.19. Rest of Europe Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
5.4.1.20. Rest of Europe Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
5.4.1.21. Rest of Europe Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Photodynamic Therapy Market Outlook, 2019-2032
6.1. Asia Pacific Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Photosensitizer Drugs
6.1.1.1.1. Hematoporphyrin derivative (HpD)
6.1.1.1.2. Aminolevulinic acid (ALA)
6.1.1.1.3. Benzoporphyrin derivative (BPD)
6.1.1.1.4. Texaphyrins
6.1.1.1.5. Chlorins
6.1.1.1.6. Dyes
6.1.1.2. Devices
6.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
6.1.1.2.2. Diode Laser
6.2. Asia Pacific Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Basal Cell Carcinoma
6.2.1.2. Actinic Keratosis
6.2.1.3. Others
6.2.1.3.1. Psoriasis
6.2.1.3.2. Acne
6.3. Asia Pacific Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Private Dermatology Clinics
6.3.1.3. Laser Therapy Centers
6.3.1.4. Cancer Treatment Centers
6.3.1.5. Spas and Rejuvenation Centers
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
6.4.1.2. China Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
6.4.1.3. China Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
6.4.1.4. Japan Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
6.4.1.5. Japan Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
6.4.1.6. Japan Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
6.4.1.7. South Korea Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
6.4.1.8. South Korea Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
6.4.1.9. South Korea Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
6.4.1.10. India Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
6.4.1.11. India Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
6.4.1.12. India Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
6.4.1.13. Southeast Asia Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
6.4.1.14. Southeast Asia Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
6.4.1.15. Southeast Asia Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
6.4.1.16. Rest of Asia Pacific Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
6.4.1.17. Rest of Asia Pacific Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
6.4.1.18. Rest of Asia Pacific Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Photodynamic Therapy Market Outlook, 2019-2032
7.1. Latin America Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Photosensitizer Drugs
7.1.1.1.1. Hematoporphyrin derivative (HpD)
7.1.1.1.2. Aminolevulinic acid (ALA)
7.1.1.1.3. Benzoporphyrin derivative (BPD)
7.1.1.1.4. Texaphyrins
7.1.1.1.5. Chlorins
7.1.1.1.6. Dyes
7.1.1.2. Devices
7.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
7.1.1.2.2. Diode Laser
7.2. Latin America Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.2.1.1. Basal Cell Carcinoma
7.2.1.2. Actinic Keratosis
7.2.1.3. Others
7.2.1.3.1. Psoriasis
7.2.1.3.2. Acne
7.3. Latin America Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Private Dermatology Clinics
7.3.1.3. Laser Therapy Centers
7.3.1.4. Cancer Treatment Centers
7.3.1.5. Spas and Rejuvenation Centers
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
7.4.1.2. Brazil Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
7.4.1.3. Brazil Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
7.4.1.4. Mexico Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
7.4.1.5. Mexico Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
7.4.1.6. Mexico Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
7.4.1.7. Argentina Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
7.4.1.8. Argentina Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
7.4.1.9. Argentina Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
7.4.1.10. Rest of Latin America Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
7.4.1.11. Rest of Latin America Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
7.4.1.12. Rest of Latin America Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Photodynamic Therapy Market Outlook, 2019-2032
8.1. Middle East & Africa Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Photosensitizer Drugs
8.1.1.1.1. Hematoporphyrin derivative (HpD)
8.1.1.1.2. Aminolevulinic acid (ALA)
8.1.1.1.3. Benzoporphyrin derivative (BPD)
8.1.1.1.4. Texaphyrins
8.1.1.1.5. Chlorins
8.1.1.1.6. Dyes
8.1.1.2. Devices
8.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
8.1.1.2.2. Diode Laser
8.2. Middle East & Africa Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Basal Cell Carcinoma
8.2.1.2. Actinic Keratosis
8.2.1.3. Others
8.2.1.3.1. Psoriasis
8.2.1.3.2. Acne
8.3. Middle East & Africa Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Private Dermatology Clinics
8.3.1.3. Laser Therapy Centers
8.3.1.4. Cancer Treatment Centers
8.3.1.5. Spas and Rejuvenation Centers
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
8.4.1.2. GCC Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
8.4.1.3. GCC Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
8.4.1.4. South Africa Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
8.4.1.5. South Africa Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
8.4.1.6. South Africa Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
8.4.1.7. Egypt Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
8.4.1.8. Egypt Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
8.4.1.9. Egypt Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
8.4.1.10. Nigeria Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
8.4.1.11. Nigeria Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
8.4.1.12. Nigeria Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Photodynamic Therapy Market by Application, Value (US$ Bn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Photodynamic Therapy Market by End User, Value (US$ Bn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Distribution Channel vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Galderma S.A.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Sun Pharmaceutical Industries Ltd.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Biofrontera
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Novartis AG
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Allergan Plc
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Quest Pharmatech, Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Valeant Pharmaceuticals International, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Hologic, Inc. (Cynosure Inc.)
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations